Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("METIROSINE")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 45

  • Page / 2
Export

Selection :

  • and

ALPHA -METHYL-P-TYROSINE INHIBITION OF A CONDITIONED AVOIDANCE RESPONSE: REVERSAL BY DOPAMINE APPLIED TO THE NUCLEUS ACCUMBENSBRACS PU; JACKSON DM; GREGORY P et al.1982; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1982; VOL. 77; NO 2; PP. 159-163; BIBL. 24 REF.Article

HPLC separation of metyrosine enantiomers as methyl esters derivatized with 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanateHEFNAWY, M. M; STEWART, J. T.Journal of liquid chromatography & related technologies. 1998, Vol 21, Num 3, pp 381-389, issn 1082-6076Article

THE MODIFICATION OF INOTROPIC ACTION OF OUABAIN BY 6-HYDROXYDOPAMINE AND ALPHA -METHYL-P-TYROSINE IN DOGS = MODIFICATION DE L'ACTION INOTROPE DE L'OUABAINE PAR L'HYDROXY-6 DOPAMINE ET L'ALPHA -METHYL-P-TYROSINE CHEZ DES CHIENSSHUDO I; SAITO H; TANABE T et al.1975; JAP. J. PHARMACOL.; JAP.; DA. 1975; VOL. 25; NO 6; PP. 639-643; BIBL. 18 REF.Article

Preliminary observations of malignant melanoma therapy using radiolabeled alpha-methyltyrosineMCLAUGHLIN, W. H; THRAMANN, W. M. JR; LAMBRECHT, R. M et al.Journal of surgical oncology. 1988, Vol 37, Num 3, pp 192-197, issn 0022-4790Article

NEUROLEPTIC MALIGNANT SYNDROME CAUSED BY DOPAMINE-DEPLETING DRUGS IN A PATIENT WITH HUNTINGTON DISEASEBURKE RE; FAHN S; MAYEUX R et al.1981; NEUROLOGY; ISSN 0028-3878; USA; DA. 1981; VOL. 31; NO 8; PP. 1022-1026; BIBL. 36 REF.Article

Inhibition of catecholamin byosynthesis by carbidopa and metyrosine in neuroblastomaANTON, A. H; CRUMRINE, R. S; STERN, R. C et al.Pediatric pharmacology (New York, NY). 1983, Vol 3, Num 2, pp 107-177, issn 0270-322XArticle

ALPHA -METHYL-P-TYROSINE: A REVIEW OF ITS PHARMACOLOGY AND CLINICAL USEBROGDEN RN; HEEL RC; SPEIGHT TM et al.1981; DRUGS (N.Y.); ISSN 0012-6667; USA; DA. 1981; VOL. 21; NO 2; PP. 81-89; BIBL. 27 REF.Article

Determination of metyrosine and its metabolite in serum by reversed phase high performance liquid chromatography using solid phase extraction and fluorescence detectionHEFNAWY, M. M; STEWART, J. T.Journal of liquid chromatography & related technologies. 1997, Vol 20, Num 18, pp 3009-3016, issn 1082-6076Article

RESPONSIVENESS OF THE RABBIT EYE TO ADRENERGIC AND CHOLINERGIC AGONISTS AFTER TREATMENT WITH 6-HYDROXYDOPAMINE OR ALPHA-METHYL-PARA-TYROSINE. I: PUPILLARY CHANGES.COLASANTI BK; KOSA JE; TROTTER RR et al.1978; ANN. OPHTHALMOL.; USA; DA. 1978; VOL. 10; NO 8; PP. 1067-1074; BIBL. 13 REF.Article

Role of dopamine in the neurotoxic effects of methamphetamineSCHMIDT, C. J; RITTER, J. K; SONSALLA, P. K et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 233, Num 3, pp 539-544, issn 0022-3565Article

Metyrosine and pheochromocytomaSTEINSAPIR, J; CARR, A. A; PRISANT, L. M et al.Archives of internal medicine (1960). 1997, Vol 157, Num 8, pp 901-906, issn 0003-9926Article

INHIBITION OF RADIOEMESIS BY DISRUPTION OF CATECHOLAMINES IN DOGSLUTHRA YK; MATTSSON JL; YOCHMOWITZ MG et al.1981; RADIAT. RES.; ISSN 0033-7587; USA; DA. 1981; VOL. 85; NO 3; PP. 583-591; BIBL. 22 REF.Article

AVOIDANCE FACILITATION BY CHLORDIAZEPOXIDE-AMPHETAMINE COMBINATIONS IN MICE: EFFECT OF ALPHA -METHYL-P-TYROSINESANSONE M; RENZI P.1981; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1981; VOL. 75; NO 1; PP. 22-24; BIBL. 22 REF.Article

Occurrence of anticancer activity of prednisolone via adrenalectomy and inhibition of adrenaline in ratsSULEYMAN, Hatis; CADIRCI, Elif; ALBAYRAK, Abdulmecit et al.International journal of cancer (Print). 2010, Vol 126, Num 7, pp 1740-1748, issn 0020-7136, 9 p.Article

ALPHA-METHYLTYROSINE IN THE MANAGEMENT OF PHAEOCHROMOCYTOMAGREEN KN; LARSSON SK; BEEVERS DG et al.1982; THORAX; ISSN 0040-6376; GBR; DA. 1982; VOL. 37; NO 8; PP. 632-633; BIBL. 5 REF.Article

LONG-TERM TREATMENT OF TARDIVE DYSKINESIA WITH PRESYNAPTICALLY ACTING DOPAMINE-DEPLETING AGENTSFAHN S.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 267-276; BIBL. 11 REF.Article

Amphetamine and α-methyl-p-tyrosine affect the exercise-induced imbalance between the availability of tryptophan and synthesis of serotonin in the brain of the ratCHAOULOFF, F; LAUDE, D; MERINO, D et al.Neuropharmacology. 1987, Vol 26, Num 8, pp 1099-1106, issn 0028-3908Article

A case of malignant pheochromocytoma: a trial of blood pressure control with labetalol and alpha-methyl-tyrosineISHIKAWA, Y; SHIONOIRI, H; YASUDA, G et al.Current therapeutic research. 1987, Vol 42, Num 3, pp 542-550, issn 0011-393XArticle

Effects of AMPT and/or inescapable shock on complex avoidance respondingFRANCOIS, G. R; CHELMOWSKI, M.The Psychological record. 1986, Vol 36, Num 3, pp 399-405, issn 0033-2933Article

Alpha-methyl-para-tyrosine effects in mice selectivity bred for differences in sensitivity to ethanolFRENCH, T. A; CLAY, K. L; MURPHY, R. C et al.Biochemical pharmacology. 1985, Vol 34, Num 21, pp 3811-3821, issn 0006-2952Article

THE FAILURE OF ALPHA-METHYL-PARA-TYROSINE TO PRODUCE SUPERSENSITIVITY IN 6-OHDA LESIONED RATSWILLIS GL; SINGER G.1980; PHARMACOL. BIOCHEM. BEHAV.; USA; DA. 1980; VOL. 12; NO 3; PP. 371-376; BIBL. 20 REF.Article

PHAEOCHROMOCYTOMA WITH MYOCARDITIS MANAGED WITH ALPHA -METHYL-P-TYROSINE.BAGNALL WE; SALWAY JG; JACKSON EW et al.1976; POSTGRAD. MED. J.; G.B.; DA. 1976; VOL. 52; NO 612; PP. 653-656; BIBL. 7 REF.Article

Spectrophotometric determination of cefadroxil and metyrosine in dosage formsALY, F. A; WALASH, M. I; BELAL, F et al.Analytical letters. 1994, Vol 27, Num 14, pp 2677-2687, issn 0003-2719Article

Perinatal dopamine-related drugs demasculinize ratsHULL, E. M; NISHITA, J. K; BITRAN, D et al.Science (Washington, D.C.). 1984, Vol 224, Num 4652, pp 1011-1013, issn 0036-8075Article

Catecholamines and pituitary function. II: Prolactin response to different dopamine doses in normal cycling women and patients with prolactin-secreting pituitary tumors, both before and after endogenous catecholamine synthesis inhibitionNICOLETTI, I; FILIPPONI, P; FEDELI, L et al.Hormone and metabolic research. 1984, Vol 16, Num 12, pp 658-662, issn 0018-5043Article

  • Page / 2